Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

Similar articles for PubMed (Select 22937411)

1.

Addition of aripiprazole to the clozapine may be useful in reducing anxiety in treatment-resistant schizophrenia.

Chanachev A, Ansermot N, Crettol Wavre S, Nowotka U, Stamatopoulou ME, Conus P, Eap CB.

Case Rep Psychiatry. 2011;2011:846489. doi: 10.1155/2011/846489. Epub 2011 Sep 14.

2.

An open comparison of clozapine and risperidone in treatment-resistant schizophrenia.

Flynn SW, MacEwan GW, Altman S, Kopala LC, Fredrikson DH, Smith GN, Honer WG.

Pharmacopsychiatry. 1998 Jan;31(1):25-9.

PMID:
9524981
3.

[Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].

Papetti F, Morel-Pingault V, Buisse V, Maziere L, Banayan M, Thauby S, Besnard T, Darcourt G, Pringuey D.

Encephale. 2007 Oct;33(5):811-8. French.

PMID:
18357853
4.

Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.

Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M.

J Clin Psychiatry. 2004 Apr;65(4):551-6.

PMID:
15119920
5.

Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.

Taylor DM, Smith L.

Acta Psychiatr Scand. 2009 Jun;119(6):419-25. doi: 10.1111/j.1600-0447.2009.01367.x. Epub 2009 Feb 25.

PMID:
19245679
6.

Practical issues with amisulpride in the management of patients with schizophrenia.

Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.

Clin Drug Investig. 2008;28(8):465-77. Review.

PMID:
18598092
8.

An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.

Krzystanek M, Krupka-Matuszczyk I.

Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9. Review.

PMID:
23055416
9.
10.

Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.

Lerma-Carrillo I, Molina JD, Cuevas-Durán T, González-Parra S, Blasco-Fontecilla H, Andrade-Rosa C, López-Muñoz F, Alamo C.

Clin Neuropharmacol. 2007 Mar-Apr;30(2):114-21. Review.

PMID:
17414944
11.

Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.

Munro J, Matthiasson P, Osborne S, Travis M, Purcell S, Cobb AM, Launer M, Beer MD, Kerwin R.

Acta Psychiatr Scand. 2004 Oct;110(4):292-8.

PMID:
15352931
12.

Augmenting amisulpride with clozapine had led to unmasking of akathisia.

Ray A, Munshi S.

Ind Psychiatry J. 2012 Jul;21(2):152-4. doi: 10.4103/0972-6748.119638.

13.

Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.

Raskin S, Katz G, Zislin Z, Knobler HY, Durst R.

Acta Psychiatr Scand. 2000 Apr;101(4):334-6.

PMID:
10782556
14.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

15.

Augmentation strategies in clozapine-resistant schizophrenia.

Remington G, Saha A, Chong SA, Shammi C.

CNS Drugs. 2005;19(10):843-72. Review.

PMID:
16185094
17.

[A rare and not very studied disorder: childhood-onset schizophrenia. A case report].

Bailly D, de Chouly de Lenclave MB.

Encephale. 2004 Nov-Dec;30(6):540-7. French.

PMID:
15738856
18.

Clozapine alone versus clozapine and risperidone with refractory schizophrenia.

Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, Falkai P, Pomarol-Clotet E, McKenna PJ, Stip E, Williams R, MacEwan GW, Wasan K, Procyshyn R; Clozapine and Risperidone Enhancement (CARE) Study Group.

N Engl J Med. 2006 Feb 2;354(5):472-82.

19.

Treatment-resistant schizophrenia: clinical experience with new antipsychotics.

Bondolfi G, Baumann P, Dufour H.

Eur Neuropsychopharmacol. 1996;6 Suppl 2:S21-5.

PMID:
8792117
20.

Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.

Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB.

Arch Gen Psychiatry. 2006 Jun;63(6):622-9.

PMID:
16754835
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk